XML 62 R30.htm IDEA: XBRL DOCUMENT v3.6.0.2
Segment Information (Tables)
 6 Months Ended
Dec. 31, 2016
Segment Reporting [Abstract]  
Revenue by Reportable Segment
The following table presents revenue for each reportable segment and Corporate:
 
Three Months Ended December 31,
(in millions)
2016
 
2015
Pharmaceutical
$
29,743

 
$
28,287

Medical
3,410

 
3,162

Total segment revenue
33,153

 
31,449

Corporate (1)
(3
)
 
(4
)
Total revenue
$
33,150

 
$
31,445

 
Six Months Ended December 31,
(in millions)
2016
 
2015
Pharmaceutical
$
58,505

 
$
53,427

Medical
6,690

 
6,081

Total segment revenue
65,195

 
59,508

Corporate (1)
(6
)
 
(9
)
Total revenue
$
65,189

 
$
59,499

(1)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following table presents segment profit by reportable segment and Corporate:
 
Three Months Ended December 31,
(in millions)
2016
 
2015
Pharmaceutical
$
537

 
$
627

Medical
159

 
106

Total segment profit
696

 
733

Corporate
(154
)
 
(170
)
Total operating earnings
$
542

 
$
563

 
Six Months Ended December 31,
(in millions)
2016
 
2015
Pharmaceutical
$
1,071

 
$
1,285

Medical
286

 
207

Total segment profit
1,357

 
1,492

Corporate
(281
)
 
(309
)
Total operating earnings
$
1,076

 
$
1,183
Assets by Reportable Segment
The following table presents total assets for each reportable segment and Corporate at:
(in millions)
December 31,
2016
 
June 30,
2016
Pharmaceutical
$
21,874

 
$
20,662

Medical
10,600

 
10,236

Corporate
2,547

 
3,224

Total assets
$
35,021

 
$
34,122